CATEGORY:

Weight Loss & Metabolism

DESCRIPTION:

Liraglutide is a once-daily GLP-1 receptor agonist used under medical supervision for blood sugar control and weight management in eligible patients. Olympia describes compounded liraglutide as supporting insulin secretion, suppressing glucagon, slowing digestion, and reducing appetite. These effects can help support metabolic balance, type 2 diabetes care, and weight loss in appropriate patients. Liraglutide is not a general wellness injection; it requires clinical screening, monitoring, education on subcutaneous administration, and review of contraindications such as certain thyroid cancer history, pancreatitis, or significant gastrointestinal disease.